Who owns GT BIOPHARMA INC COM NEW?
- Ticker: GTBP
- CUSIP Number: 36254l308
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 452k | $184k | 100% | Mar 2026 |
|
| Geode Capital Management | 295k | $120k | 1429% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 226k | $92k | 100% | Mar 2026 |
|
| SRS Capital Advisors | 94k | $38k | 100% | Mar 2026 |
|
| Citadel Advisors | 66k | $27k | -18% | Mar 2026 |
|
| SeaCrest Wealth Management | 50k | $20k | 0% | Mar 2026 |
|
| UBS Group | 46k | $19k | 4596900% | Mar 2026 |
|
| Two Sigma Securities | 32k | $13k | 154% | Mar 2026 |
|
| LPL Financial | 30k | $12k | 186% | Mar 2026 |
|
| Invst | 23k | $9.5k | 100% | Mar 2026 |
|
| Keel Point | 21k | $8.5k | 100% | Mar 2026 |
|
| HPM Partners | 20k | $8.2k | 33% | Mar 2026 |
|
| Integrated Wealth Concepts | 20k | $8.2k | 0% | Mar 2026 |
|
| Private Wealth Management Group | 20k | $8.2k | 100% | Mar 2026 |
|
| Coston, McIsaac & Partners | 17k | $6.0k | 0% | Mar 2026 |
|
| Morgan Stanley | 17k | $6.8k | -11% | Mar 2026 |
|
| Caitlin John | 17k | $6.7k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 16k | $6.5k | 0% | Mar 2026 |
|
| Am Investment Strategies | 15k | $6.0k | 0% | Mar 2026 |
|
| Intl Fcstone | 15k | $6.0k | 100% | Mar 2026 |
|
| Verdence Capital Advisors | 12k | $4.9k | -8% | Mar 2026 |
|
| Prospera Financial Services | 12k | $4.9k | 0% | Mar 2026 |
|
| LaSalle St. Investment Advisors | 11k | $4.5k | 100% | Mar 2026 |
|
| Parsons Capital Management | 11k | $4.4k | 0% | Mar 2026 |
|
| HBK Sorce Advisory | 10k | $3.8k | 0% | Mar 2026 |
|
| Advisory Services Network | 10k | $7.9k | 100% | Dec 2025 |
|
| BlackRock | 8.4k | $3.4k | 0% | Mar 2026 |
|
| Newbridge Financial Services Group | 3.8k | $1.5k | 0% | Mar 2026 |
|
| Massmutual Trust | 3.0k | $1.2k | 100% | Mar 2026 |
|
| Farther Finance Advisors | 3.0k | $1.2k | 0% | Mar 2026 |
|
| West Financial Advisors | 2.5k | $1.0k | 100% | Mar 2026 |
|
| Atlantic Trust | 2.0k | $1.6k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 2.0k | $1.6k | -61% | Dec 2025 |
|
| Tower Research Capital | 1.7k | $1.3k | 0% | Dec 2025 |
|
| Triumph Capital Management | 1.7k | $675.074500 | 0% | Mar 2026 |
|
| Stone House Investment Management | 1.3k | $510.032700 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 126.00 | $0 | 100% | Mar 2026 |
|
| Hilltop National Bank | 100.00 | $41.000000 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 16.00 | $7.000000 | 0% | Mar 2026 |
|
| SBI Securities | 1.00 | $0 | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Scientech Research | Dec 2025 | 55k | $43k |
| Jane Street | Dec 2025 | 26k | $20k |
| Hrt Financial | Dec 2025 | 12k | $9.0k |
| Vanguard Group | Sep 2025 | 11k | $6.2k |
| Wolff Wiese Magana | Dec 2025 | 5.0k | $3.9k |
| SWAN Capital | Dec 2025 | 1.0k | $785.000000 |
| Spire Wealth Management | Dec 2025 | 994.00 | $784.961800 |
| Jones Financial Companies, L.L | Sep 2025 | 300.00 | $230.010000 |
| Jpmorgan Chase & Co | Sep 2025 | 1.00 | $1.000000 |